ArticleJournal of gastrointestinal oncology2016
Undifferentiated embryonal sarcoma of the liver with an unusual presentation: case report and review of the literature.
Article in Journal of gastrointestinal oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 15 citations in OpenAlex.
- Large Undifferentiated Sarcoma of the Liver: A Rare Case Report and Literature Review.Clinical case reports · 2026Article
- Adult Primary Hepatic Sarcoma Presenting as a Chronic Expanding Hematoma.Surgical case reports · 2026Article
- Article
- A rare case of embryonal sarcoma in the liver of a young adult: diagnostic and therapeutic perspectives.Radiology case reports · 2024Article
- Management of undifferentiated embryonal sarcoma of the liver: A Pediatric Surgical Oncology Research Collaborative study.Pediatric blood & cancer · 2024Article
- An Adult With Undifferentiated Embryonal Sarcoma of the Liver: A Case Report of a Rare Encounter.Cureus · 2023Article
- Undifferentiated embryonal sarcoma of the liver occurring in an adolescent: a case report with genomic analysis.Surgical case reports · 2022Article
- Review
- Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review.Hepatic oncology · 2020Review
- The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss.PLoS genetics · 2020Article
- Article
- Pulmonary Metastases from an Undifferentiated Embryonal Sarcoma of the Liver: A Case Report and Review.Case reports in oncological medicine · 2018Article
- Adult Embryonal Sarcoma of the Liver: Management of a Massive Liver Tumor.Case reports in surgery · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Undifferentiated embryonal sarcoma of the liver (UESL) is a rare malignant mesenchymal neoplasm, relatively unique to the liver that occurs primarily in children and teenagers. Delay in diagnosis is not uncommon due to lack of a characteristic clinical presentation, serological markers and radiological changes. We report a case of UESL in a 9-year-old girl who presented with right upper quadrant pain and a palpable mass. Laboratory and imaging workup revealed a complex hepatic cyst, increased IgE, transient peripheral eosinophilia and a normal alpha-fetoprotein (AFP). Initial empirical treatment with albendazole was implemented for presumed hydatid cyst disease, but the child failed to improve. Subsequent surgical resection resulted in the correct diagnosis of UESL. She received 6 months of chemotherapy and remains well with no evidence of tumor about 12 months after resection. We herein review the typical clinical, radiologic and pathologic features of this rare tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.